Oxolife will present its newest evidences on OXO-001 in fertility and embryo implantation in the American Society for … [Read more...] about OXOLIFE presents the latest results in the ASRM21
Today, Oxolife founders Agnès Arbat and Ignasi Canals are in the international event 4YFN - 4 Years from Now, hold in … [Read more...] about OXOLIFE IS PRESENT IN THE 4YFN – MWC
The European Society of Human Reproduction and Embryology (ESHRE) has accepted our second communication for its … [Read more...] about OXOLIFE has two accepted communications in the ESHRE Annual Meeting
The Ministry of Science and Innovation has awarded us the seal of small and medium-sized innovative company. From now … [Read more...] about Oxolife has been recognized as an innovative SME
Today we have a BIG new! We want to announce that the protocol and documents for the phase II clinical trial of … [Read more...] about The phase II clinical trial protocol and documents have been submitted!
At the end of June, the European Society of Human Reproduction and Embryology (ESHRE) organizes its 37th Annual Meeting … [Read more...] about OXOLIFE will participate in the ESHRE 37th Annual Meeting